Assembly Biosciences Total Liabilities 2010-2025 | ASMB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Assembly Biosciences total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Assembly Biosciences Total Liabilities 2010-2025 | ASMB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Assembly Biosciences total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$18.7B
Dr Reddy's Laboratories (RDY)	$12.1B
BridgeBio Pharma (BBIO)	$8.7B
Bausch Health Cos (BHC)	$2.3B
Supernus Pharmaceuticals (SUPN)	$1.9B
Amphastar Pharmaceuticals (AMPH)	$999M
Personalis (PSNL)	$548M
Taysha Gene Therapies (TSHA)	$543M
Sol-Gel Technologies (SLGL)	$23M
Evoke Pharma (EVOK)	$7M
Teligent (TLGT)	$0M